TY  - GEN
AU  - Liu,Liang
AU  - Yang,Lin
AU  - Mi,Yingchang
AU  - Wang,Jianxiang
AU  - Li,Jianyong
AU  - Zhang,Yue
AU  - Ma,Xiaotang
AU  - Qin,Tiejun
AU  - Xu,Zefeng
AU  - Xiao,Zhijian
TI  - RAD51 and XRCC3 polymorphisms: impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ-MYH11(+) acute myeloid leukemia
SN  - 1873-5835
PY  - 2011///0929
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Case-Control Studies
KW  - Child
KW  - Child, Preschool
KW  - Chromosome Inversion
KW  - Chromosomes, Human, Pair 16
KW  - genetics
KW  - DNA, Neoplasm
KW  - DNA-Binding Proteins
KW  - Female
KW  - Follow-Up Studies
KW  - Genotype
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - Male
KW  - Middle Aged
KW  - Oncogene Proteins, Fusion
KW  - Polymerase Chain Reaction
KW  - Polymorphism, Genetic
KW  - Polymorphism, Restriction Fragment Length
KW  - Rad51 Recombinase
KW  - Retrospective Studies
KW  - Survival Rate
KW  - Translocation, Genetic
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.leukres.2011.01.014
ER  -